2
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Neoplasms
5
Pain
3
Cachexia
3
Breast Neoplasms
3
Trigger Finger Disorder
2
Prostatic Neoplasms
2
Lymphoma, Follicular
2
Lung Neoplasms
2
Inflammation
2
Ganglion Cysts
2
De Quervain Disease
2
Colorectal Neoplasms
2
Weight Loss
1
Uveal Melanoma
1
Uterine Cervical Neoplasms
1
Supratentorial Brain Tumor
1
Stomach Neoplasms
1
Rectal Neoplasms
1
Prostatitis
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pleural Effusion, Malignant
1
Pituitary Neoplasms
1
Patient Satisfaction
1
Pancreatic Neoplasms
1
Oropharyngeal Neoplasms
1
Nose Neoplasms
1
Neoplasm Metastasis
1
Mucositis
1
Menorrhagia
1
Interventions
Bupivacaine
11
Ketamine
9
Ropivacaine
8
Morphine
8
Analgesics, Opioid
8
Acetaminophen
8
Fentanyl
7
Dexmedetomidine
7
Lidocaine
6
Anesthesia, General
6
Saline Solution
5
Anesthesia, Local
5
Acupuncture Therapy
5
parecoxib
4
Tramadol
4
Surveys and Questionnaires
4
Sodium Chloride
4
Pregabalin
4
Ethanol
4
Analgesia, Epidural
4
Transcutaneous Electric Nerve Stimulation
3
Radiofrequency Ablation
3
Propofol
3
Oxycodone
3
Ketorolac
3
Control Groups
3
Anesthetics, Local
3
trimebutine 3-thiocarbamoylbenzenesulfonate
2
Therapeutics
2
Tea
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Agnosia
×
Ibuprofen
×
Clear all
NCT00299039
2009-02-02
T3AI
Nova Scotia Health Authority
Phase 3
Completed
150 enrolled